David Turkaly

Stock Analyst at JMP Securities

(2.13)
# 2,961
Out of 5,033 analysts
140
Total ratings
39.06%
Success rate
-4.49%
Average return

Stocks Rated by David Turkaly

OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35$25
Current: $17.24
Upside: +45.01%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112$73
Current: $55.60
Upside: +31.29%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $15.07
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $59.58
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $50.26
Upside: +98.97%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265$280
Current: $240.21
Upside: +16.56%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35$25
Current: $15.08
Upside: +65.78%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62$55
Current: $31.42
Upside: +75.05%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140$125
Current: $101.92
Upside: +22.65%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400$500
Current: $484.65
Upside: +3.17%
Reiterates: Market Perform
Price Target: n/a
Current: $374.42
Upside: -
Reiterates: Market Perform
Price Target: n/a
Current: $128.13
Upside: -
Maintains: Market Outperform
Price Target: $12$7
Current: $1.53
Upside: +357.52%
Reiterates: Market Outperform
Price Target: $26
Current: $16.59
Upside: +56.72%
Reiterates: Market Outperform
Price Target: $32
Current: $14.74
Upside: +117.10%
Reiterates: Market Outperform
Price Target: $16
Current: $7.65
Upside: +109.15%
Reiterates: Market Perform
Price Target: n/a
Current: $2.92
Upside: -
Maintains: Market Outperform
Price Target: $7$3
Current: $2.69
Upside: +11.52%
Initiates: Outperform
Price Target: $5
Current: $7.95
Upside: -37.11%